Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 4 | |
Outperform | 5 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for Vor Biopharma Inc have a median target of 12.00, with a high estimate of 18.00 and a low estimate of 3.00. The median estimate represents a 1,152.61% increase from the last price of 0.958.
High | 1,778.9% | 18.00 |
Med | 1,152.6% | 12.00 |
Low | 213.2% | 3.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 18, 2025.
Average growth rate | +4.09% |
Average growth rate | +37.68% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼